Association Analysis of Polymorphisms in Genes Related to Oxidative Stress in South Indian Type 2 Diabetic Patients with Retinopathy

References

• Rema M, Premkumar S, Anitha B, et al. Prevalence of diabetic retinopathy in urban India: The Chennai Urban Rural Epidemiology Study (CURES) Eye Study, I. Invest Ophthalmol Vis Sci 2005;46:2328–2333
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BEK, Moss SE, Cruickshanks KJ. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med 1994;154:2169–2178
   PubMed Web of Science ®Google Scholar
• DCCT. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995;44:968–983
   PubMed Web of Science ®Google Scholar
• Stratton IM, Adler AI, Neil HAW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405–412
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang M, Morris AD, et al. Glycemic exposure and blood pressure influencing progression and remission of diabetic retinopathy: a longitudinal cohort study in GoDARTS. Diabetes Care 2013;36:3979–3984
   PubMed Web of Science ®Google Scholar
• Ceriello A. Oxidative stress and diabetes-associated complications. Endocr Pract 2006;12:60–62
   PubMedGoogle Scholar
• Nishikawa T, Edelstein D, Brownlee M. The missing link: a single unifying mechanism for diabetic complications. Kidney Int 2000;77:S26–S30
   Google Scholar
• Du Y, Miller CM, Kern TS. Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med 2003;35:1491–1499
   PubMed Web of Science ®Google Scholar
• Leslie RD, Pyke DA. Diabetic retinopathy in identical twins. Diabetes 1982;31:19–21
   PubMed Web of Science ®Google Scholar
• Hietala K, Forsblom C, Summanen P, Groop PH. Heritability of proliferative diabetic retinopathy. Diabetes 2008;57:2176–2180
   PubMed Web of Science ®Google Scholar
• Danser AH, Derkx FH, Admiraal PJ, et al. Angiotensin levels in the eye. Invest Ophthalmol Vis Sci 1994;35:1008–1018
   PubMed Web of Science ®Google Scholar
• Nagi DK, Mansfield MW, Stickland MH, Grant PJ. Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism, and diabetic retinopathy in subjects with IDDM and NIDDM. Diabet Med 1995;12:997–1001
   PubMed Web of Science ®Google Scholar
• Doi Y, Yoshizumi H, Yoshinari M, et al. Association between a polymorphism in the angiotensin converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 1996;39:97–102
   PubMed Web of Science ®Google Scholar
• Araz M, Yilmaz N, Gungor K, et al. Angiotensin-converting enzyme gene polymorphism and microvascular complications in Turkish type 2 diabetic patients. Diabetes Res Clin Pract 2001;54:95–104
   PubMed Web of Science ®Google Scholar
• Toda N, Nakanishi-Toda M. Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy. Prog Retin Eye Res 2007;26:205–238
   PubMed Web of Science ®Google Scholar
• Awata T, Neda T, Iizuka H, et al. Endothelial nitric oxide synthase gene is associated with diabetic macular edema in type 2 diabetes. Diabetes Care 2004;27:2184–2190
   PubMed Web of Science ®Google Scholar
• Ezzidi I, Mtiraoui N, Mohamed MB, et al. Endothelial nitric oxide synthase, Glu298Asp, 4b/a, and T-786C polymorphisms in type 2 diabetic retinopathy. Clin Endocrinol 2008;68:542–546
   PubMed Web of Science ®Google Scholar
• de Syllos RW, Sandrim VC, Lisboa HR, et al. Endothelial nitric oxide synthase genotype and haplotype are not associated with diabetic retinopathy in type 2 diabetes patients. Nitric Oxide 2006;15:417–422
   PubMed Web of Science ®Google Scholar
• Suganthalakshmi B, Anand R, Kim R, et al. Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy. Mol Vis 2006;12:336–341
   PubMed Web of Science ®Google Scholar
• Uthra S, Raman R, Mukesh BN, et al. Intron 4 VNTR of endothelial nitric oxide synthase (eNOS) gene and diabetic retinopathy in type 2 patients in southern India. Ophthalmic Genet 2007;28:77–81
   PubMed Web of Science ®Google Scholar
• Al-Shabrawey M, Bartoli M, El-Remessy A, et al. Role of NADPH Oxidase and Stat3 in statin-mediated protection against diabetic retinopathy. Invest Ophthalmol Vis Sci 2008;49:3231–3238
   PubMed Web of Science ®Google Scholar
• Matsunaga-Irie S, Maruyama T, Yamamoto Y, et al. Relation between development of nephropathy and the p22phox C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients. Diabetes Care 2004;27:303–307
   PubMed Web of Science ®Google Scholar
• Zheng L, Szabó C, Kern TS. Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes 2004;53:2960–2967
   PubMed Web of Science ®Google Scholar
• Mabley JG, Feng Y, Hagen F, et al. Poly(ADP-ribose) polymerase and diabetic retinopathy. FASEB J 2004;18:A1189
   Google Scholar
• Lunn RM, Langlois RG, Hsieh LL, et al. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 1999;59:2557–2561
   PubMed Web of Science ®Google Scholar
• Lahiri DK, Nurnberger JI. A rapid nonenzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nuc Acids Res 1991;19:5444
   PubMed Web of Science ®Google Scholar
• Obrosova IG, Minchenko AG, Frank RN, et al. Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression. Int J Mol Med 2004;14:55–64
   PubMed Web of Science ®Google Scholar
• Wang XG, Wang ZQ, Tong WM, Shen Y. PARP1 Val762Ala polymorphism reduces enzymatic activity. Biochem Biophys Res Commun 2007;354:122–126
   PubMed Web of Science ®Google Scholar
• Caldecott KW, Aoufouchi S, Johnson P, Shall S. XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly ADP-ribose polymerase, and DNA ligase III is a novel molecular ‘nick-sensor’ in vitro. Nucleic Acids Res 1996;24:4387–4394
   PubMed Web of Science ®Google Scholar
• Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 1998;58:604–608
   PubMed Web of Science ®Google Scholar
• Fujisawa T, Ikegami H, Kawaguchi Y, et al. Meta-analysis of association of insertion/deletion polymorphism of angiotensin 1 converting enzyme with diabetic nephropathy and retinopathy. Diabetologia 1998;41:47–53
   PubMed Web of Science ®Google Scholar
• Lu Y, Ge Y, Hu Q, et al. Association between angiotensin-converting enzyme gene polymorphism and diabetic retinopathy in the Chinese population. J Renin Angiotensin Aldosterone Syst 2012;13:289–295
   PubMed Web of Science ®Google Scholar
• Neugebauer S, Baba T, Watanabe T. Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes 2000;49:500–503
   PubMed Web of Science ®Google Scholar
• Shimizu T, Onuma T, Kawamori R, et al. Endothelial nitric oxide synthase gene and the development of diabetic nephropathy. Diabetes Res Clin Pract 2002;58:179–185
   PubMed Web of Science ®Google Scholar
• Abhary S, Hewitt AW, Burdon KP, Craig JE. A systematic meta-analysis of genetic association studies for diabetic retinopathy. Diabetes 2009;58:2137–2147
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520–526
   PubMed Web of Science ®Google Scholar
• Kohner EM. Diabetic retinopathy. Br Med Bull 1989;45:148–173
   PubMed Web of Science ®Google Scholar
• Ferris FL 3rd, Chew KY, Hoogwerf BJ. Serum lipids and diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group. Diabetes Care 1996;19:1291–1293
   PubMed Web of Science ®Google Scholar
• Fernandez-Robredo P, Moya D, Rodriguez JA, Garcia-Layana A. Vitamins C and E reduce retinal oxidative stress and nitric oxide metabolites and prevent ultrastructural alterations in porcine hypercholesterolemia. Invest Ophthalmol Vis Sci 2005;46:1140–1146
   PubMed Web of Science ®Google Scholar